Fujifilm Diosynth Biotechnologies Is A Global Contract Development And Manufacturing Organizationcdmothat Specializes In Biologicsvaccinesadvanced Therapiesand Oncolytic Virusesformed Through A Partnership Between Fujifilm Corporation And Mitsubishi Corporationthe Company Operates Facilities In The Uknorth Carolinatexasand Denmarkwith Over 30 Years Of Experienceit Focuses On The Development And Manufacturing Of Recombinant Proteinsmonoclonal Antibodiesand Viral Products The Company Offers End To End Cdmo Solutionsincluding Cell Line Developmentprocess Developmentanalytical Testingand Regulatory Compliant Manufacturingits Commercial Manufacturing Capabilities Are Supported By Fda Approved Facilities For Biologics And Vaccinesin 2023Fujifilm Diosynth Restructured Into Strategic Business Unitssbusto Enhance Customer Supportwith Dedicated Units For Large Scale And Small Scale Productionthe Holly Springs Facility Is Set To Become North America S Largest Cell Culture Cdmo Sitewith Significant Expansions Planned To Meet The Growing Demand For Biologics
